What is amoxicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Amoxicillin?

Amoxicillin is a semisynthetic aminopenicillin β-lactam antibiotic with bactericidal activity against Gram-positive and some Gram-negative bacteria, acting by inhibiting bacterial cell wall synthesis and inducing autolysis. 1

Mechanism of Action and Pharmacology

  • Amoxicillin inhibits bacterial cell wall biosynthesis during active multiplication, leading to bacterial death through disruption of peptidoglycan synthesis 1
  • It is the most active oral β-lactam against streptococci, including pneumococci, due to excellent oral bioavailability 2
  • The drug is stable in gastric acid and rapidly absorbed after oral administration, with peak blood levels occurring 1-2 hours post-dose 1
  • Approximately 60% is excreted unchanged in urine within 6-8 hours, with a half-life of 61.3 minutes 1
  • Amoxicillin is approximately 20% protein-bound and diffuses readily into most body tissues and fluids (except brain and spinal fluid unless meninges are inflamed) 1

Antimicrobial Spectrum

  • Gram-positive coverage: Streptococcus pneumoniae, Streptococcus pyogenes, non-hospital Staphylococcus aureus, and enterococci (more active than ampicillin against enterococci) 3, 4
  • Gram-negative coverage: Haemophilus influenzae (non-β-lactamase producing), Moraxella catarrhalis (non-β-lactamase producing), Escherichia coli, and Salmonella species 3, 4
  • Critical limitation: Amoxicillin is destroyed by β-lactamases produced by both Gram-positive and Gram-negative bacteria 1, 4

Clinical Indications

Respiratory Tract Infections

  • First-line agent for community-acquired pneumonia when S. pneumoniae is the suspected pathogen 5
  • Acute bacterial sinusitis in patients without risk factors for resistant organisms 5
  • Acute otitis media in children without recent antibiotic exposure or daycare attendance 5
  • Bacterial exacerbations of bronchitis 4

Other Infections

  • Acute lower urinary tract infections 4
  • Gonorrhea 4
  • Typhoid fever 4
  • In specialized settings: oral therapy for endocarditis, septic arthritis, osteomyelitis, and endocarditis prophylaxis 4

Standard Dosing

Adults

  • Standard dose: 1.5-1.75 g/day or 3 g/day for respiratory infections 5, 2
  • Oral doses of 250-500 mg produce peak levels of 3.5-7.5 mcg/mL 1

Pediatric Patients

  • Pneumonia in children <3 years: 80-100 mg/kg/day in three divided doses (for children <30 kg) 5
  • Acute bacterial sinusitis (uncomplicated): 45 mg/kg/day in 2 divided doses for children ≥2 years without risk factors 5
  • High-dose regimen: 80-90 mg/kg/day in 2 divided doses (maximum 2 g/dose) for children with risk factors or in communities with >10% penicillin-nonsusceptible S. pneumoniae 5
  • Dosing should be modified in neonates and infants ≤12 weeks due to incompletely developed renal function 1

Resistance Considerations

  • Resistance in S. pneumoniae is relative and can be overcome with higher doses 2
  • 10-15% of upper respiratory S. pneumoniae isolates nationally are penicillin-nonsusceptible (up to 50-60% in some areas) 5
  • 10-42% of H. influenzae and nearly 100% of M. catarrhalis produce β-lactamases, rendering them resistant to amoxicillin alone 5
  • Risk factors for resistance: daycare attendance, antibiotic use within 30 days, age <2 years 5

Amoxicillin-Clavulanate Combination

  • Clavulanic acid is a potent β-lactamase inhibitor that preserves amoxicillin activity against β-lactamase-producing bacteria 2, 6
  • This combination maintains full activity against S. pneumoniae while achieving 95-100% effectiveness against H. influenzae and 100% against M. catarrhalis 2
  • High-dose formulation: 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate (pediatric) or 4 g amoxicillin with 250 mg clavulanate daily (adult) 5, 2
  • The clavulanate component limits maximum daily amoxicillin dosing due to gastrointestinal adverse effects 2

Important Clinical Pearls

  • Amoxicillin has superior oral absorption compared to ampicillin, achieving blood levels 2-2.5 times higher 4
  • When costs are comparable, amoxicillin should replace ampicillin as the oral aminopenicillin of first choice 4
  • Renal dose adjustment required for severe renal impairment (GFR <30 mL/min) 1
  • Probenecid delays amoxicillin excretion by competing for renal tubular secretion 1
  • Overdosage can cause crystalluria and interstitial nephritis; amoxicillin is removable by hemodialysis 1

References

Guideline

Amoxicilina y Amoxicilina-Clavulánico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amoxicillin-sulbactam: A clinical and therapeutic review.

Drugs of today (Barcelona, Spain : 1998), 2001

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Introduction: historical perspective and development of amoxicillin/clavulanate.

International journal of antimicrobial agents, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.